Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04205799
Title Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure (CABOCOL-01)
Acronym CABOCOL-01
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.